Crainio Non-invasive ICP Monitor for TBI
Key facts
- Who runs it
- Crainio Ltda
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 54 people, planned
- Started
- 15 May 2025
- Expected to end
- 15 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Crainio
- Record updated
- 18 March 2026
Who can take part
- Age
- 16 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Clinical diagnosis of traumatic brain injury
- Adults (aged between 16 and 99, male and female)
- TBI patients admitted to the Royal London Hospital
- Patients having invasive ICP monitoring as part of their normal medical treatment
Who cannot take part
- Forehead skin is not intact
- Decompressive craniectomy patients
- Open external ventricular drainage (EVD) treatment
- Patients who will unlikely survive the following twelve hours
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 16 and 99 years old?
This trial is currently available in United Kingdom.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The clinical investigation aims to advance the Crainio device, designed for non-invasive intracranial pressure (ICP) monitoring. This feasibility study involves 54 participants over a 12-month period and seeks to collect cerebral photoplethysmogram signals alongside concurrent invasive ICP measurements in patients with traumatic brain injury. The primary objective is to establish the diagnostic accuracy of the Crainio device, aiming for at least 90% sensitivity and specificity in detecting raised ICP (above 20 mmHg). Secondary objectives include evaluating patient-related factors such as skin tone, skull thickness, and skull density, as well as the tolerability and acceptance of the device by both patients and healthcare professionals.
The group in the trial
- CrainioTreatment being tested
Acquisition of cerebral PPG signals from Crainio's probe stuck to the patient's forehead, alongside concurrent invasive ICP measurements in patients with traumatic brain injury
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Crainio Non-invasive Intracranial Pressure Monitor for Traumatic Brain Injury: Product Development
- Criteria questions
- Built from NCT06453733, who can take part
- Record updated
- 18 March 2026